Literature DB >> 10837696

Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) - genetic predisposition and metabolic abnormalities.

.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM), also known as type II diabetes, is characterized by abnormal glucose homeostasis, resulting in hyperglycemia, and is associated with microvascular, macrovascular, and neuropathic complications. NIDDM is a complex disease with many causes. Both genetic and environmental factors play important roles in the pathogenesis of NIDDM. Cumulative evidence on the high prevalence of NIDDM in certain ethnic groups, the high concordance rate for the disease in monozygotic twins, familial aggregation, and familial transmission patterns suggests that the genetic component plays an important etiological role in the development of NIDDM. In genetically predisposed individuals, there is a slow progression from a normal state to hyperglycemia, largely due to a combination of insulin resistance and defects in insulin secretion. Although numerous candidate genes responsible for insulin resistance and for the defects in insulin secretion have been reported, no specific gene(s) accounting for the majority of cases of the common type of NIDDM has been identified. Considerable evidence indicates that environmental and other factors, including diet, stress, physical activity, obesity and aging, also play an important role in the development of the disease. In conclusion, the pathogenic process of NIDDM depends on a complex interaction between genetic and environmental factors.

Entities:  

Year:  1999        PMID: 10837696     DOI: 10.1016/s0169-409x(98)00071-4

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  7 in total

1.  Controlled release of modified insulin glargine from novel biodegradable injectable gels.

Authors:  Om Anand; Hassan Almoazen; Nitin Mehrotra; James Johnson; Atul Shukla
Journal:  AAPS PharmSciTech       Date:  2012-01-19       Impact factor: 3.246

2.  Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori.

Authors:  N R Poa; G J S Cooper; P F Edgar
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

Review 3.  Heart failure and diabetes: role of ATM.

Authors:  Mary C Wingard; Chad R Frasier; Mahipal Singh; Krishna Singh
Journal:  Curr Opin Pharmacol       Date:  2020-08-01       Impact factor: 5.547

Review 4.  The health of Arab-Americans living in the United States: a systematic review of the literature.

Authors:  Abdulrahman M El-Sayed; Sandro Galea
Journal:  BMC Public Health       Date:  2009-07-30       Impact factor: 3.295

5.  Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice.

Authors:  Marija Dokmanovic-Chouinard; Wendy K Chung; Jean-Claude Chevre; Elizabeth Watson; Jason Yonan; Beebe Wiegand; Yana Bromberg; Nao Wakae; Chris V Wright; John Overton; Sujoy Ghosh; Ganesh M Sathe; Carina E Ammala; Kathleen K Brown; Rokuro Ito; Charles LeDuc; Keely Solomon; Stuart G Fischer; Rudolph L Leibel
Journal:  PLoS Genet       Date:  2008-07-25       Impact factor: 5.917

Review 6.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29

7.  Preventive effects of Morus alba L. anthocyanins on diabetes in Zucker diabetic fatty rats.

Authors:  Ariya Sarikaphuti; Thamthiwat Nararatwanchai; Teruto Hashiguchi; Takashi Ito; Sita Thaworanunta; Kiyoshi Kikuchi; Yoko Oyama; Ikuro Maruyama; Salunya Tancharoen
Journal:  Exp Ther Med       Date:  2013-07-04       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.